TransMedics Group, Inc. (TMDX) Key Statistics & Financial Ratios

TransMedics Group, Inc. (TMDX) — Price $82.73 — Healthcare — Medical - Devices — NASDAQ

Latest reported results:

Key statistics dashboard for TransMedics Group, Inc. (TMDX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs.

Stock Data

Price$82.73
Market Cap$2.9B
Enterprise Value$3.23B
Beta2.08
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio18.56
Price / Book5.48
P/S4.24
EV/EBITDA26.93
EV/Sales4.83
EV/FCF40.87
P/FCF35.87
Earnings Yield5.35%
FCF Yield2.79%

Profitability

Gross Margin58.69%
EBIT Margin14.03%
EBITDA Margin17.95%
Operating Margin12.21%
Net Margin22.69%
Return on Equity32.97%
Return on Assets10.36%
Return on Invested Capital5.87%
Return on Capital Employed5.97%

Financial Health

Current Ratio6.62
Quick Ratio6.07
Cash Ratio4.81
Debt / Equity1.67
Debt / Assets59.25%
Net Debt / EBITDA3.29
Interest Coverage3.84

Per-Share Data

Revenue per share19.33
Book Value per share14.98
Cash per share13.67
FCF per share2.29
Tangible Book Value per share14.65
Dividend per share0.00

Related companies: AKRO · BRKR · GKOS · HNGE · IMVT · INDV · KYMR

Explore sector: Healthcare · Medical - Devices

More sections of TMDX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks